Abstract:Objective: Disruption of B cell homeostasis and subsequent dominance of effector B cell subsets are critical for the development of systemic lupus erythematosus (SLE). Revealing the key intrinsic regulators involved in the homeostatic control of B cells has important therapeutic value for SLE. This study was undertaken to determine the regulatory role of the transcription factor Pbx1 in B cell homeostasis and lupus pathogenesis. Methods: We constructed mice with B cell-specific deletion of Pbx1. T cell-dependent and T cell-independent humoral responses were induced by intraperitoneal injection of nitrophenyl-containing hapten (NP) conjugated to keyhole limpet hemocyanin or NP-Ficoll. The regulatory effects of Pbx1 on autoimmunity were observed in a Bm12-induced lupus murine model. We investigated mechanisms of Pbx1 using RNA sequencing, the cleavage under targets and tagmentation assay, and chromatin immunoprecipitation-quantitative polymerase chain reaction assay. We transduced B cells from SLE patients with plasmids that overexpressed PBX1 to explore the in vitro therapeutic efficacy of PBX1. Results: Pbx1 was specifically down-regulated in autoimmune B cells and negatively correlated with disease activity. The deficiency of Pbx1 in B cells resulted in excessive humoral responses following immunization. In the Bm12-induced lupus model, mice with B cell-specific Pbx1 deficiency displayed enhancements in germinal center responses, plasma cell differentiation, and autoantibody production. Pbx1-deficient B cells had increased survival and proliferative advantages after activation. Pbx1 regulated genetic programs by directly targeting critical components of the proliferation and apoptosis pathways. In SLE patients, PBX1 expression was negatively correlated with effector B cell expansion; when PBX1 expression was enforced, the survival and proliferative capacity of SLE B cells were attenuated. Conclusion: Our study reveals the regulatory function and mechanism of Pbx1 in adjusting B cell homeostasis and highlights Pbx1 as a therapeutic target in SLE.

Sirtuin 1 (sirt1) Overexpression in BaF3 Cells Contributes to Cell Proliferation Promotion, Apoptosis Resistance and Pro-Inflammatory Cytokine Production

Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target

Sirtuin 1 inhibits lipopolysaccharide-induced inflammation in chronic myelogenous leukemia k562 cells through interacting with the Toll-like receptor 4-nuclear factor κ B-reactive oxygen species signaling axis

Increase of Hspa1a and Hspa1b genes in the resting B cells of Sirt1 knockout mice

Promotion of SIRT1 Protein Degradation and Lower SIRT1 Gene Expression Via Reactive Oxygen Species is Involved in Sb-induced Apoptosis in BEAS-2b Cells

The Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus

Sirt1 Exerts Anti-Inflammatory Effects and Promotes Steroidogenesis in Leydig Cells

Sirt1 Overexpression Antagonizes Cellular Senescence with Activated Erk/S6k1 Signaling in Human Diploid Fibroblasts

STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells.

Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

Enhanced Apoptosis And Senescence Of Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus

Tlr9-Induced Mir-155 And Ets-1 Decrease Expression Of Cd1d On B Cells In Sle

Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies*

Sirt1 Ameliorates Systemic Sclerosis by Targeting the Mtor Pathway.

Research Progress of Sirt1 in Immune Regulation

Decreased Sirt3 Expression Confers Growth Advantage in Chronic Lymphocytic Leukemia Cells (766.8)

Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress.

Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

Sirt1 is responsible for antigen presentation in B cells through induction of CIITA expression and CIITA deacetylation

Mysm1/Mir-150/Flt3 Inhibits B1a Cell Proliferation